Summary
Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Nautilus Biotechnology, Inc. (NAUT) Q4 2025 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NAUT) Q4 2025 Earnings Call Transcript
Nautilus Biotechnology, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 83,043 | $204,798.84 | $142,003.53 | -$62,795.31 | -30.66% |
| DS David Spratt Badgley Phelps Wealth Managers LLC | 30,000 | $70,200 | $52,050 | -$18,150 | -25.85% |
| RF Rekah Franca Catalyst Funds Management Pty Ltd. | 46,328 | $179,753 | $80,379.08 | -$99,373.92 | -55.28% |
| DWC David W. Chenet Presidio Capital Management LLC | 34,664 | $47,778.93 | $60,835.32 | $13,056.39 | 27.33% |
| MK Malinda Khauv Cercano Management LLC | 7.17M | $12.91M | $12.41M | -$502,108.95 | -3.89% |
Nautilus Biotechnology, Inc. (NAUT) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Nautilus Biotechnology, Inc. ever had a stock split?
Nautilus Biotechnology, Inc. Profile
| Biotechnology Industry | Healthcare Sector | Sujal Patel CEO | NASDAQ (NGS) Exchange | 63909J108 CUSIP |
| US Country | 127 Employees | - Last Dividend | - Last Split | 10 Jun 2021 IPO Date |
Overview
Nautilus Biotechnology, Inc. is a groundbreaking life sciences company in its development stage, focusing on revolutionizing the proteomics field. Founded in 2016 and based in Seattle, Washington, the company aims to significantly advance the understanding and quantification of the proteome through its innovative platform technology. The proteome, a complex array of proteins present in any biological sample, holds critical information for understanding human health and disease. By developing technologies to deeply analyze this complexity, Nautilus Biotechnology seeks to unlock new insights in biology, diagnostics, and therapeutic development.
Products and Services
- Nautilus Platform
An all-encompassing proteomics platform designed by Nautilus Biotechnology, this revolutionary system promises to bring unprecedented depth and precision to proteome analysis. It is an end-to-end solution featuring a combination of instruments, consumables, and sophisticated software for data analysis. The platform aims to facilitate a comprehensive understanding of the proteome's complexity, driving forward biological research and potential clinical applications.
- Proteome Analysis System
This high-resolution optical imaging system stands at the core of the Nautilus Platform, integrating advanced fluidics and liquid handling subsystems. Its design is tailored for seamless operation, enabling detailed and efficient analysis of protein samples. The system's capability to provide in-depth proteome insights through its state-of-the-art imaging technology positions it as a critical tool for researchers and clinicians alike.
- Sample Preparation and Multi-Affinity Probe Reagents
To complement its proteome analysis system, Nautilus offers a range of products designed for optimal sample preparation. This includes flow cells for sample input and multi-affinity probe reagents specially formulated for the capture and analysis of a wide array of proteins. These components are crucial for enhancing the system's sensitivity and specificity, thereby maximizing the quality and reliability of the proteomic data generated.
- Instrument Buffers and Multi-Cycle Analysis Run System
Supporting the operational needs of its platforms, Nautilus provides specifically designed instrument buffers and a system that allows for multi-cycle analysis runs. These solutions are engineered to ensure the platforms' smooth and effective performance during extended proteomics experiments. By facilitating multi-cycle runs, Nautilus Biotechnology enables more exhaustive and comprehensive proteome analyses, advancing the depth of biological insights that can be obtained.
